Sign inJoin waitlistJoin the waitlist

Angela Rivers

Professor · University of California (San Francisco) School of Medicine

Credentials: · · · · · · ·

History

Pediatric Hematology/Oncology
University of Florida College of Medicine
2007–2010
Internal Medicine
University of South Florida Morsani College of Medicine
2003–2006
Stanford University School of Medicine
1998–2002
University of Florida
1994–1998

Research

Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
PLoS ONE · 2013 · 87 citations
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
Blood · 2015 · 85 citations
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease
Experimental Hematology · 2017 · Last of 12 authors · Corresponding · 83 citations

Robert Molokie
8 papers
Andrew Campbell
7 papers
Biree Andemariam
6 papers
Connie Piccone
6 papers
Crawford Strunk
6 papers
Deepa Manwani
6 papers
DB
Donna Boruchov
6 papers
WZ
William Zempsky
6 papers
Samuel Wilson
5 papers
Yogen Saunthararajah
4 papers
William Slayton
3 papers
Ahmed Owda
2 papers · 2 as a fellow

Grants

The Role of Erythrocyte Mitochondrial Retention in Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2M · University of California, San Francisco
2019–2025
Mitophagy as Potential Target in Sickle Cell Disease
National Heart, Lung, and Blood Institute · R03
Contact PI · $159.9K · University of Illinois at Chicago
2016–2018
Development of AAV Vectors for the Phenotypic Correction of Sickle Cell Disease
National Heart, Lung, and Blood Institute · K01
Contact PI · $696.8K · University of Illinois at Chicago
2010–2016